Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million
ABOS•Q2 operating results
Aug. 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q2 operating expenses were USD 32.556 million.
- Q2 basic EPS: USD -0.45
- Q2 net income: USD -32.718 million vs. IBES estimate USD -23.3 million
